title: A patient treated with olanzapine developing diabetes de novo: proposal for hyperglycaemia screening.
abstract: We report a patient with schizophrenia who developed diabetes mellitus during treatment with olanzapine. The case confirms the pattern of atypical antipsychotic-related diabetic emergencies: rapid onset in relatively young patients, often with severe glucose derangements and serious complications. As diabetic emergencies have a high morbidity and mortality, regular glucose screening should be performed in patients with schizophrenia treated with atypical antipsychotics.
authors.affiliation: Department of Internal Medicine, Wilhelmina Hospital, Assen, the Netherlands.
authors.forename: M L
authors.initials: ML
authors.lastname: Duiverman
authors.forename: D
authors.initials: D
authors.lastname: Cohen
authors.forename: W
authors.initials: W
authors.lastname: van Oven
authors.forename: P
authors.initials: P
authors.lastname: Nieboer
mesh_terms: D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use; D001569:Benzodiazepines / Q000009:adverse effects* / Q000627:therapeutic use; D044383:Black People; D003924:Diabetes Mellitus, Type 2 / Q000139:chemically induced* / Q000150:complications / Q000188:drug therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D009426:Netherlands; D000077152:Olanzapine; D012563:Schizophrenia, Paranoid / Q000188:drug therapy*
chemical_list: D014150:Antipsychotic Agents; D001569:Benzodiazepines; D000077152:Olanzapine